AHA BHA BLEMISH CONTROL AND EXFOLIATING SERUM- salicylic acid serum liquid

AHA BHA Blemish Control and Exfoliating Serum by

Drug Labeling and Warnings

AHA BHA Blemish Control and Exfoliating Serum by is a Otc medication manufactured, distributed, or labeled by Banuskin, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Salicylic Acid 2.0%

Purpose

Acne Treatment

Uses

For the treatment of acne

Warnings

For external use only

When using this product

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Direction

• Cleanse skin thoroughly before applying product.
• Cover the entire affected area with a thin layer one to three times daily.
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other Information

Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.

Inactive Ingredient

Aqua/Water/Eau, Isopentyldiol, Squalane, Dipropylene Glycol, Hydroxypropyl Starch Phosphate, Mandelic Acid, Niacinamide, Sodium Hydroxide, Citric Acid, Succinic Acid, Phenoxyethanol, Lactobacillus ferment lysate, Xanthan Gum, Alpha-glucan oligosaccharide, Hydrogenated Lecithin, Sclerotium Gum, Lecithin, Pullulan, Allantoin, Bisabolol, Sodium Phytate, Potassium Sorbate, Sodium Benzoate, Silica, 1,2-Hexanediol, Hydroxyacetophenone, Sodium Hyaluronate, Ethylhexylglycerin.

Questions or comments?

Questions or comments?

www.banuskin.com

855-215-2268

DOSAGE & ADMINISTRATION

Topical Liquid (Serum)

SPL UNCLASSIFIED SECTION

banu

AHA + BHA BLEMISH CONTROL & EXFOLIATING SERUM

2% Salicylic Acid

Acne Treatment

SAFE FOR ACNE-PRONE SKIN

30 mL/1 fl.oz

Labels

30 mL Bottle Carton

30 mL Bottle

INGREDIENTS AND APPEARANCE

AHA BHA BLEMISH CONTROL AND EXFOLIATING SERUM 
salicylic acid serum liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85439-0101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	2 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
NIACINAMIDE (UNII: 25X51I8RD4)
CITRIC ACID (UNII: 2968PHW8QP)
XANTHAN GUM (UNII: TTV12P4NEE)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
ISOPENTYLDIOL (UNII: 19NOL5474Q)
SQUALANE (UNII: GW89575KF9)
HYDROXYPROPYL STARCH (UNII: 9M44R3409A)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
PULLULAN (UNII: 8ZQ0AYU1TT)
BISABOLOL (UNII: 24WE03BX2T)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
ALPHA-GLUCAN OLIGOSACCHARIDE (UNII: S95658MI3W)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM HYALURONATE (UNII: YSE9PPT4TH)
WATER (UNII: 059QF0KO0R)
MANDELIC ACID (UNII: NH496X0UJX)
SODIUM PHYTATE (UNII: 88496G1ERL)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
SUCCINIC ACID (UNII: AB6MNQ6J6L)
SCLEROTIUM GUM (UNII: 2X51AD1X3T)
ALLANTOIN (UNII: 344S277G0Z)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85439-0101-1	30 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	04/15/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	04/15/2025

Labeler - Banuskin, Inc. (119398280)

Registrant - Banuskin, Inc. (119398280)